Market Overview

UPDATE: Jefferies Upgrades Ventas to Buy; Both a Defensive and Growth Play

Share:
Related VTR
Ventas Announces Form 10 Filing For Spin-Off Of Post-Acute/Skilled Nursing Facility Portfolio
Jefferies Healthcare REIT Summit: Key Investor Takeaways
May Stock Considerations (Seeking Alpha)

Jefferies upgraded Ventas (NYSE: VTR) from Hold to Buy and raised the price target from $66.00 to $72.00.

Jefferies commented, "Given macro uncertainties heading into 2013, VTR offers investors a nice mix of defense and growth. A solid acquisition outlook, and another year of strong results from the senior housing operating portfolio also suggests upside to 2013 consensus estimates. We are upgrading to Buy and raising our PT to $72 from $66."

Ventas closed at $64.76 on Monday.

Latest Ratings for VTR

DateFirmActionFromTo
Apr 2015BMO CapitalMaintainsMarket Perform
Apr 2015BMO CapitalInitiates Coverage onMarket Perform
Feb 2015BarclaysMaintainsEqual-weight

View More Analyst Ratings for VTR
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Upgrades Intraday Update Analyst Ratings

 

Related Articles (VTR)

Around the Web, We're Loving...

Get Benzinga's Newsletters